What is the typical loading dose of amiodarone (antiarrhythmic medication) for treating life-threatening arrhythmias?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amiodarone Loading Dose for Life-Threatening Arrhythmias

For life-threatening arrhythmias, the recommended loading dose of amiodarone is 150 mg IV administered over 10 minutes (which may be repeated if necessary), followed by 1 mg/min for 6 hours, then 0.5 mg/min thereafter, with a total dose not exceeding 2.2 g over 24 hours. 1

Intravenous Loading Protocol

  • The FDA-approved intravenous loading protocol for amiodarone in life-threatening ventricular arrhythmias consists of approximately 1000 mg over the first 24 hours, delivered in three phases 1:

    • Initial load: 150 mg IV over 10 minutes (in 100 mL D5W)
    • Followed by: 1 mg/min infusion for 6 hours (360 mg)
    • Followed by: 0.5 mg/min infusion thereafter (720 mg per 24 hours)
  • For breakthrough episodes of ventricular fibrillation or hemodynamically unstable ventricular tachycardia, repeat the initial 150 mg loading dose 1

  • The onset of antiarrhythmic effect occurs rapidly, typically in less than 30 minutes 2

Administration Considerations

  • Amiodarone must be delivered by a volumetric infusion pump, preferably through a central venous catheter dedicated to that purpose 1

  • Use an in-line filter during administration to prevent particulate matter 1

  • For concentrations greater than 2 mg/mL, a central venous catheter is required to minimize phlebitis 1

  • Amiodarone infusions exceeding 2 hours must be administered in glass or polyolefin bottles containing D5W 1

  • Do not exceed an initial infusion rate of 30 mg/min to avoid severe hypotension 1

Oral Loading Dose

  • For patients requiring oral loading (for stable ventricular arrhythmias), the recommended dose is 800 to 1,600 mg per day in divided doses until a total of 10 g has been administered 2, 3

  • After the loading phase, reduce to a maintenance dose of 200 to 400 mg per day 2, 3

Monitoring and Adverse Effects

  • The most common adverse reactions during IV amiodarone administration include 1:

    • Hypotension (most common, occurring in approximately 26% of patients) 4
    • Bradycardia and AV block
    • Hepatocellular necrosis and acute renal failure (with excessively rapid infusion)
  • If hypotension occurs, slow the infusion rate and consider adding vasopressor drugs, positive inotropic agents, or volume expansion 1

  • If bradycardia or AV block develops, slow the infusion or discontinue administration 1

  • Patients with severe left ventricular dysfunction are at higher risk of developing significant hypotension during the loading phase 5

Clinical Considerations

  • Dose-response studies have demonstrated that higher loading doses (1000 mg/24 hours) are more effective than lower doses (125 mg/24 hours) in suppressing life-threatening ventricular arrhythmias 4

  • The time to first arrhythmic event increases and the number of supplemental boluses needed decreases with higher loading doses 4

  • For patients transitioning from IV to oral therapy, the oral dosing should be based on duration of IV therapy, with higher oral doses (800-1,600 mg daily) recommended for patients who received IV therapy for less than one week 3

  • Amiodarone shows considerable interindividual variation in response, so close monitoring with dose adjustment is essential 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.